Arsenic trioxide and retinoic acid work together to target the master regulator protein Pin1, a new study shows. In cancer cell lines and mice, the drug combination slowed the growth of triple-negative breast cancer tumors.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2MMnav2